The investigators will review all adverse events that are associated with pediatric sedation for MRI/CT
The Incidence and Nature of Adverse Events During Pediatric Sedation for MRI/CT in One Korean University Hospital: Retrospective Study
Brief Summary
Sedation and anesthesia for diagnostic imaging represents a rapidly growing field of practice, especially in children. Propofol is the most common sedative drug administered for MRI/CT. However, this drug is associated with adverse events, including pulmonary complications, and there has been no report on these complications in Korea.
The investigators reviewed 3739 charts of pediatric patients sedated for MRI/CT between January and November 2012.
In this study, the investigators will report the nature and frequency of adverse events associated with sedation for MRI/CT between January and November 2012.
Intervention / Treatment
-
pediatric sedation (propofol, ketamine, etc) (DRUG)Presedation assessment was performed by hospitalists and pediatric sedation was performed by protocol in the sedation unit. Data on demographics, primary illness, ASA, snoring history, URI symptom, medications used, procedure and recovery times, medication doses, outcomes of anesthesia, airway interventions and adverse events were collected retrospectively.
Condition or Disease
- Children Requiring Sedation for MRI/CT
Phase
Study Design
Study type: | OBSERVATIONAL |
---|---|
Status: | Unknown status |
Study results: | No Results Available |
Age: | up to 18 Years (Child, Adult) |
Enrollment: | 3739 (ESTIMATED) |
Funded by: | Other |
Time Perspective: | Retrospective |
Masking |
Clinical Trial Dates
Start date: | Nov 01, 2012 | |
---|---|---|
Primary Completion: | Jul 01, 2013 | ESTIMATED |
Completion Date: | Oct 01, 2013 | ESTIMATED |
Study First Posted: | May 16, 2013 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | May 13, 2013 |
Sponsors / Collaborators
Location
Participant Groups
-
Children requiring sedation for MRI/CT
Eligibility Criteria
Sex: | All |
---|---|
Maximum Age: | 18 |
Age Groups: | Child / Adult |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* Requiring sedation for MRI/CT, aged 0- 18 years
Exclusion Criteria:
* None
* Requiring sedation for MRI/CT, aged 0- 18 years
Exclusion Criteria:
* None
Primary Outcomes
More Details
NCT Number: | NCT01855581 |
---|---|
Other IDs: | 4-2012-0923 |
Study URL: | https://clinicaltrials.gov/study/NCT01855581 |
Last updated: Sep 29, 2023